EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Preferential cytotoxicity of crude drugs used in J apanese K ampo medicines against human pancreatic cancer PANC ‐1 and PSN ‐1 cells

Sullim Lee, Dya F. Dibwe, Feng Li, Hiroyuki Morita, Yasuhiro Tezuka

Traditional & Kampo Medicine · 2015

DOI: 10.1002/tkm2.1016 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Aim Pancreatic cancer is the most aggressive cancer of all and has an exceptionally high global mortality rate, ranking seventh as the most frequent cause of cancer death. In order to identify an anti‐pancreatic cancer drug, we screened 24 crude drugs used in K ampo medicine for preferential cytotoxicity based on anti‐austerity strategy. Methods Preferential cytotoxicity was determined by comparing the cytotoxicities against PANC ‐1 and PSN ‐1 human pancreatic cancer cells in normal medium ( DMEM ) and nutrient‐deprived medium. The extracts that showed potent activity were then examined for the mechanism of cell death on ethidium bromide/acridine orange ( EB / AO ) double staining. Results Among the 24 extracts examined, extract of andrographis herba (aerial part of Andrographis paniculata ) had the most potent preferential cytotoxicity against both cell lines, with concentration at which 50% of cells died preferentially in NDM ( PC 50 ) of 9.72 µg/mL ( PANC ‐1) and 9.41 µg/mL ( PSN ‐1), and extracts of isodonis herba (aerial part of Plectranthus japonicas ), phellodendri cortex (bark of Phellodendron amurense ), licopodium (spore of Lycopodium clavatum ), and panacis japonici rhizoma (radix of Panax japonicas ) had mild activity. On EB / AO double‐staining of cells treated by these extracts, isodonis herba, licopodium, and panacis japonici rhizoma induced apoptosis‐like cell death under nutrient starvation, whereas phellodendri cortex and andrographis herba induced necrosis‐like cell death. Conclusion The crude drugs used in J apanese K ampo medicines, isodonis herba, phellodendri cortex, licopodium, andrographis herba, and panacis japonici rhizoma, could be used in the treatment of pancreatic cancer and/or as sources of anti‐pancreatic cancer drugs.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →